Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
NAAS Rating: 5.03 new
Vol. 4, Issue 1 (2015)

Differential Access to Treating Of Drug-Induced Hepatotoxicity in Patients with Chronic Lymphocytic Leukemia

Grydguk T.І.
In this article abilities of differential administration of hepatoprotective medications are observed regarding a type of drug-induced liver injury during chemotherapy in patients with chronic lymphocytic leukemia. The type of drug-induced liver injury was determined depending on the grade of increasing of aminotransferase and alkaline phosphatase levels. Effectiveness of arginine glutamate at presence of cytolitic type of drug-induced liver injury and ursosan at presence of cholestatic type of drug-induced liver injury was studied. It was determined that including of these medicines in basic therapy of drug-induced liver injury promotes normalization of biochemical indexes that characterize functional state of liver parenchyma and enables to provide chemotherapy courses of chronic lymphocytic leukemia completely.
Pages: 17-20  |  860 Views  11 Downloads
How to cite this article:
Grydguk T.І.. . The Pharma Innovation Journal. 2015; 4(1): 17-20.
Journals List Click Here Research Journals Research Journals
Call for book chapter
The Pharma Innovation Journal